Computational chemist John Chodera uses statistical mechanics, molecular modeling, and automated biophysical experiments to help identify new potential therapeutics and investigate mechanisms of drug resistance in cancer.

The Choi Lab develops new synthetic biology tools to study cell-fate decisions in development.

Arvin Dar’s lab develops chemical tools and probes to explore disease mechanisms and the structural biology of cancer targets.

Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.

The Kushal Dey lab focuses on developing machine learning models and computational pipelines that integrate genomic and epigenomic data.

The Diehl lab studies how the microbiota and other exogenous factors regulate development and function of the intestinal immune system.

The Diver lab studies the physiological roles and molecular mechanisms of understudied membrane-embedded proteins with the goal of revealing novel therapeutic targets for diseases such as pain and cancer.

The Farese & Walther lab studies the biology and pathology of cellular lipid metabolism, focusing on lipid/energy storage in lipid droplets and sphingolipid metabolism in lysosomes.

Lydia Finley studies the mechanisms that link metabolic pathways to cell fate decisions.

Cell biologist Hironori Funabiki focuses on regulation of the structure and configuration of chromosomes during the cell division cycle.